Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 3Cholangiocarcinoma 3Neoplasms 1Hemobilia 1Gallbladder Neoplasms 1Choledocholithiasis 1Cholangitis, Sclerosing 1Biliary Tract Neoplasms 1Biliary Tract Diseases 1Biliary Fistula 1Bile Duct Neoplasms 1Bile Duct Diseases 1

Interventions

Liquid Biopsy 4Blood Specimen Collection 4Gemcitabine 3pembrolizumab 2Immunohistochemistry 2Cisplatin 2Capecitabine 2Base Sequence 2130-nm albumin-bound paclitaxel 2tislelizumab 1taxane 1lenvatinib 1irinotecan sucrosofate 1gemcitabine-oxaliplatin regimen 1Tegafur 1Taxes 1Surgical Procedures, Operative 1Standard of Care 1S 1 (combination) 1Polymerase Chain Reaction 1Platinum Compounds 1Oxaliplatin 1Nivolumab 1Microscopy, Confocal 1Methylation 1Mass Spectrometry 1Leucovorin 1Irinotecan 1Immune Checkpoint Inhibitors 1High-Throughput Nucleotide Sequencing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Biliary Tract Neoplasms × Cholangiopancreatography, Endoscopic Retrograde × Clear all
NCT03504293 2020-12-22

The Diagnostic Value of Combinatory EUS and ERCP in Unclear Lesions

Sahlgrenska University Hospital

Completed
90 enrolled
Gastrointestinal

Biliary Tract Diseases, Biliary Tract Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡